chevron_leftBack
As of 13 June 2026, Vivos Inc. has a market cap of $33.65M USD, ranking #33445 globally and #4715 in the United States.
It ranks #3019 in the Healthcare sector, and #635 in the Medical Devices industry.
Key Stats
Market Cap
$33.65MUSD
Enterprise Value
$41.55MUSD
Revenue (TTM)
$68.38KUSD
EBITDA (TTM)
-$3.16MUSD
Net Income (TTM)
-$3.07MUSD
PS Ratio
492.1
PB Ratio
20.3
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Michael Korenko
open_in_new
Employees
1
Founded
1994
Website
radiogel.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -2% | -0.5% | -23% | -4.1% | -6.8% | -44% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
RDGL
Vivos Inc
ISIN: US92858K2042
Shares Out.:
Shares Outstanding:
493.891M1
Shares Float:
474.713M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0686 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Vivos Inc.
Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. The company develops an yttrium-90 based precision radionuclide therapy device; RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing a universal laboratory cooling device; hydrogel; and other products under the Alpha-Gel, Beta-Gel, Gamma-Gel, and Precisiongel names. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc. in December 2017. Vivos Inc. was incorporated in 1994 and is headquartered in Kennewick, Washington.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
515K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
478K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
473K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
376K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
359K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
252K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
303K%
|
22.2
|
|
EPA: EL
|
$97.46B
290K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$61.41B
182K%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.47B
135K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.38B
108K%
28.99B CHF
|
37.9
|
|
|
$30.06B
89K%
203.66B CNY
|
26.0
|
chevron_leftBack